Earnings ·
Thermo Fisher Scientific reported second quarter 2026 financial results for the period ended June 27, 2026
TMOThermo Fisher Scientific Inc.
Thermo Fisher Scientific reported second quarter 2026 financial results for the period ended June 27, 2026. Revenue increased 10% to $11.99 billion, representing 5% organic growth. GAAP diluted earnings per share grew 9% to $4.68, while adjusted EPS rose 13% to $6.03. The company reported GAAP operating income of $2.09 billion and adjusted operating income of $2.73 billion. During the quarter, the company announced the divestiture of its microbiology business and repurchased $1.0 billion of stock. Thermo Fisher Scientific is a global provider of scientific instrumentation, analytical instruments, and laboratory solutions.